Comments on: Immatics Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial https://insideout.vn/immatics-announces-updated-phase-1b-clinical-data-on-actengine-ima203-tcr-t-targeting-prame-in-melanoma-patients-and-provides-update-on-upcoming-suprame-phase-3-trial/ Inside Out Thu, 10 Oct 2024 10:31:21 +0000 hourly 1 https://wordpress.org/?v=6.6.2